Teleflex [TFX] vs Repligen [RGEN] Detailed Stock Comparison
Teleflex
NYSE
Loading...
Repligen
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Teleflex wins in 15 metrics, Repligen wins in 4 metrics, with 0 ties. Teleflex appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Teleflex | Repligen | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 29.05 | 511.11 | Teleflex |
| Price-to-Book Ratio | 1.30 | 3.40 | Teleflex |
| Debt-to-Equity Ratio | 49.49 | 33.28 | Repligen |
| PEG Ratio | 8.16 | 3.19 | Repligen |
| EV/EBITDA | 8.03 | 55.34 | Teleflex |
| Profit Margin (TTM) | 6.31% | -2.05% | Teleflex |
| Operating Margin (TTM) | 24.16% | 5.28% | Teleflex |
| EBITDA Margin (TTM) | 24.16% | 5.28% | Teleflex |
| Return on Equity | 4.36% | -0.68% | Teleflex |
| Return on Assets (TTM) | 5.41% | 1.13% | Teleflex |
| Free Cash Flow (TTM) | $509.31M | $142.49M | Teleflex |
| Dividend Yield | 0.87% | N/A | N/A |
| 1-Year Return | -46.61% | -14.99% | Repligen |
| Price-to-Sales Ratio (TTM) | 1.81 | 10.42 | Teleflex |
| Enterprise Value | $7.34B | $7.00B | Teleflex |
| EV/Revenue Ratio | 2.42 | 10.38 | Teleflex |
| Gross Profit Margin (TTM) | 55.20% | 49.98% | Teleflex |
| Revenue per Share (TTM) | $66 | $12 | Teleflex |
| Earnings per Share (Diluted) | $4.29 | $-0.25 | Teleflex |
| Beta (Stock Volatility) | 1.08 | 1.05 | Repligen |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Teleflex vs Repligen Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Teleflex | -1.44% | 7.24% | 12.34% | 7.01% | -27.14% | -27.72% |
| Repligen | -2.83% | 0.35% | 9.35% | 3.60% | -24.25% | -12.76% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Teleflex | -46.61% | -42.26% | -66.39% | -2.32% | 158.68% | 91.25% |
| Repligen | -14.99% | -45.06% | -16.91% | 263.93% | 3,581.12% | 3,356.79% |
Performance & Financial Health Analysis: Teleflex vs Repligen
| Metric | TFX | RGEN |
|---|---|---|
| Market Information | ||
| Market Cap | $5.51B | $7.02B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 587,090 | 697,970 |
| 90 Day Avg. Volume | 584,093 | 934,717 |
| Last Close | $127.55 | $121.26 |
| 52 Week Range | $108.90 - $249.91 | $102.97 - $182.52 |
| % from 52W High | -48.96% | -33.56% |
| All-Time High | $449.38 (Apr 26, 2021) | $327.32 (Sep 20, 2021) |
| % from All-Time High | -71.62% | -62.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.15% |
| Quarterly Earnings Growth | 0.53% | 1.60% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | -0.02% |
| Operating Margin (TTM) | 0.24% | 0.05% |
| Return on Equity (TTM) | 0.04% | -0.01% |
| Debt to Equity (MRQ) | 49.49 | 33.28 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $96.01 | $36.65 |
| Cash per Share (MRQ) | $5.92 | $12.60 |
| Operating Cash Flow (TTM) | $514.28M | $132.11M |
| Levered Free Cash Flow (TTM) | $360.29M | $155.35M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.87% | N/A |
| Last 12-Month Dividend | $1.02 | N/A |
Valuation & Enterprise Metrics Analysis: Teleflex vs Repligen
| Metric | TFX | RGEN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 29.05 | 511.11 |
| Forward P/E | 8.16 | 70.11 |
| PEG Ratio | 8.16 | 3.19 |
| Price to Sales (TTM) | 1.81 | 10.42 |
| Price to Book (MRQ) | 1.30 | 3.40 |
| Market Capitalization | ||
| Market Capitalization | $5.51B | $7.02B |
| Enterprise Value | $7.34B | $7.00B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.42 | 10.38 |
| Enterprise to EBITDA | 8.03 | 55.34 |
| Risk & Other Metrics | ||
| Beta | 1.08 | 1.05 |
| Book Value per Share (MRQ) | $96.01 | $36.65 |
Financial Statements Comparison: Teleflex vs Repligen
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TFX | RGEN |
|---|---|---|
| Revenue/Sales | $780.89M | $182.37M |
| Cost of Goods Sold | $349.80M | $91.22M |
| Gross Profit | $431.09M | $91.14M |
| Research & Development | $38.52M | $13.96M |
| Operating Income (EBIT) | $177.48M | $5.96M |
| EBITDA | $244.84M | $33.81M |
| Pre-Tax Income | $135.25M | $18.22M |
| Income Tax | $12.66M | $3.35M |
| Net Income (Profit) | $122.58M | $14.87M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TFX | RGEN |
|---|---|---|
| Cash & Equivalents | $284.12M | $697.23M |
| Total Current Assets | $1.54B | $1.03B |
| Total Current Liabilities | $675.91M | $152.00M |
| Long-Term Debt | $1.90B | $668.54M |
| Total Shareholders Equity | $4.10B | $1.99B |
| Retained Earnings | $4.20B | $413.18M |
| Property, Plant & Equipment | $627.26M | $265.24M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TFX | RGEN |
|---|---|---|
| Operating Cash Flow | $109.80M | $14.16M |
| Capital Expenditures | N/A | $-3.52M |
| Free Cash Flow | $43.08M | $10.58M |
| Debt Repayment | $-49.13M | N/A |
| Common Stock Repurchase | $-300.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TFX | RGEN |
|---|---|---|
| Shares Short | 882,529 | 3.64M |
| Short Ratio | 1.52 | 3.98 |
| Short % of Float | 0.03% | 0.09% |
| Average Daily Volume (10 Day) | 587,090 | 697,970 |
| Average Daily Volume (90 Day) | 584,093 | 934,717 |
| Shares Outstanding | 46.27M | 56.09M |
| Float Shares | 44.03M | 52.66M |
| % Held by Insiders | 0.00% | 0.06% |
| % Held by Institutions | 1.02% | 1.05% |
Dividend Analysis & Yield Comparison: Teleflex vs Repligen
| Metric | TFX | RGEN |
|---|---|---|
| Last 12-Month Dividend | $1.02 | N/A |
| Last 12-Month Dividend Yield | 0.87% | N/A |
| 3-Year Avg Annual Dividend | $1.13 | N/A |
| 3-Year Avg Dividend Yield | 0.16% | N/A |
| 3-Year Total Dividends | $3.40 | N/A |
| Ex-Dividend Date | Mar 07, 2025 | N/A |